zenith laboratories inc said received food and drug administration approval market cephalexin antibiotic generic version eli lilly inc keflex generic drugs low cost copies brand name drugs have lost patents keflex patent expires april analysts said four generic drug companies including zenith will have approval market generic keflex this year analysts said keflex lilly second leading drug product with 1986 worldwide sales about 335 mln dlrs 1986 lilly had sales billion dlrs think first year loses its patent sales keflex will drop about 240 mln dlrs from 280 mln dlrs said joe riccardo associate director bear stearns riccardo said lilly would offset loss with sales from humatrope genetically engineered human growth hormone recently approved for marketing also said was likely lilly would fda marketing approval this year for prozac drug for treating clinical depression also shows promise weight reduction reuter 